Cargando…

Bi-directional exosome-driven intercommunication between the hepatic niche and cancer cells

BACKGROUND: Our understanding of the multiple roles exosomes play during tumor progression is still very poor and the contribution of the normal tissue derived exosomes in distant seeding and tumor outgrowth has also not been widely appreciated. METHODS: Using our all-human liver microphysiological...

Descripción completa

Detalles Bibliográficos
Autores principales: Dioufa, Nikolina, Clark, Amanda M., Ma, Bo, Beckwitt, Colin H., Wells, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686836/
https://www.ncbi.nlm.nih.gov/pubmed/29137633
http://dx.doi.org/10.1186/s12943-017-0740-6
_version_ 1783278845806247936
author Dioufa, Nikolina
Clark, Amanda M.
Ma, Bo
Beckwitt, Colin H.
Wells, Alan
author_facet Dioufa, Nikolina
Clark, Amanda M.
Ma, Bo
Beckwitt, Colin H.
Wells, Alan
author_sort Dioufa, Nikolina
collection PubMed
description BACKGROUND: Our understanding of the multiple roles exosomes play during tumor progression is still very poor and the contribution of the normal tissue derived exosomes in distant seeding and tumor outgrowth has also not been widely appreciated. METHODS: Using our all-human liver microphysiological system (MPS) platform as a model to closely recapitulate the early metastatic events, we isolated exosomes from both tumor cells and liver microenvironment. RESULTS: We observed that while priming of the hepatic niche (HepN) with MDA-231 breast cancer derived exosomes facilitated seeding of the cancer cells in the liver, subsequent tumor outgrowth was diminished; this was consistent with increased entry into dormancy. We found that hepatic niche (HepN) derived exosomes contribute significantly to the exosome pool and are distinguished from cancer derived exosomes based on their size, protein and miRNA content. By Ingenuity Pathway Analysis (IPA) of the miRNA content of the HepN, MDA-231/HepN and MDA-231 cells we showed that the HepN derived exosomes affect the breast cancer cells by suppressing pathways involved in cancer cell proliferation and invasion. More importantly exposure of MDA-231 and MDA-468 cells to purified normal HepN derived exosomes, induced changes in the cells consistent with a Mesenchymal to Epithelial reverting Transition (MErT). miRNA arrays performed on MDA-231 treated with Hum Hep/NPC derived exosomes showed significant changes in the levels of a select number of miRNAs involved in epithelial cell differentiation and miRNAs, such as miR186, miR23a and miR205, from our top and bottom bins have previously been reported to regulate E-cadherin transcription and MErT induction in various cancer types. Consistently HepN derived exosome treatment of breast and prostate cancer lines lead to a transient induction of E-cadherin and ZO-1 at the protein level and a more epithelial-like morphology of the cells. CONCLUSIONS: Collectively our data revealed a novel mechanism of regulation of the metastatic cascade, showing a well-orchestrated, timely controlled crosstalk between the cancer cells and the HepN and implicating for the first time the normal tissue/HepN derived exosomes in enabling seeding and entry into dormancy of the cancer cells at the metastatic site. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12943-017-0740-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5686836
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56868362017-11-21 Bi-directional exosome-driven intercommunication between the hepatic niche and cancer cells Dioufa, Nikolina Clark, Amanda M. Ma, Bo Beckwitt, Colin H. Wells, Alan Mol Cancer Research BACKGROUND: Our understanding of the multiple roles exosomes play during tumor progression is still very poor and the contribution of the normal tissue derived exosomes in distant seeding and tumor outgrowth has also not been widely appreciated. METHODS: Using our all-human liver microphysiological system (MPS) platform as a model to closely recapitulate the early metastatic events, we isolated exosomes from both tumor cells and liver microenvironment. RESULTS: We observed that while priming of the hepatic niche (HepN) with MDA-231 breast cancer derived exosomes facilitated seeding of the cancer cells in the liver, subsequent tumor outgrowth was diminished; this was consistent with increased entry into dormancy. We found that hepatic niche (HepN) derived exosomes contribute significantly to the exosome pool and are distinguished from cancer derived exosomes based on their size, protein and miRNA content. By Ingenuity Pathway Analysis (IPA) of the miRNA content of the HepN, MDA-231/HepN and MDA-231 cells we showed that the HepN derived exosomes affect the breast cancer cells by suppressing pathways involved in cancer cell proliferation and invasion. More importantly exposure of MDA-231 and MDA-468 cells to purified normal HepN derived exosomes, induced changes in the cells consistent with a Mesenchymal to Epithelial reverting Transition (MErT). miRNA arrays performed on MDA-231 treated with Hum Hep/NPC derived exosomes showed significant changes in the levels of a select number of miRNAs involved in epithelial cell differentiation and miRNAs, such as miR186, miR23a and miR205, from our top and bottom bins have previously been reported to regulate E-cadherin transcription and MErT induction in various cancer types. Consistently HepN derived exosome treatment of breast and prostate cancer lines lead to a transient induction of E-cadherin and ZO-1 at the protein level and a more epithelial-like morphology of the cells. CONCLUSIONS: Collectively our data revealed a novel mechanism of regulation of the metastatic cascade, showing a well-orchestrated, timely controlled crosstalk between the cancer cells and the HepN and implicating for the first time the normal tissue/HepN derived exosomes in enabling seeding and entry into dormancy of the cancer cells at the metastatic site. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12943-017-0740-6) contains supplementary material, which is available to authorized users. BioMed Central 2017-11-14 /pmc/articles/PMC5686836/ /pubmed/29137633 http://dx.doi.org/10.1186/s12943-017-0740-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Dioufa, Nikolina
Clark, Amanda M.
Ma, Bo
Beckwitt, Colin H.
Wells, Alan
Bi-directional exosome-driven intercommunication between the hepatic niche and cancer cells
title Bi-directional exosome-driven intercommunication between the hepatic niche and cancer cells
title_full Bi-directional exosome-driven intercommunication between the hepatic niche and cancer cells
title_fullStr Bi-directional exosome-driven intercommunication between the hepatic niche and cancer cells
title_full_unstemmed Bi-directional exosome-driven intercommunication between the hepatic niche and cancer cells
title_short Bi-directional exosome-driven intercommunication between the hepatic niche and cancer cells
title_sort bi-directional exosome-driven intercommunication between the hepatic niche and cancer cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686836/
https://www.ncbi.nlm.nih.gov/pubmed/29137633
http://dx.doi.org/10.1186/s12943-017-0740-6
work_keys_str_mv AT dioufanikolina bidirectionalexosomedrivenintercommunicationbetweenthehepaticnicheandcancercells
AT clarkamandam bidirectionalexosomedrivenintercommunicationbetweenthehepaticnicheandcancercells
AT mabo bidirectionalexosomedrivenintercommunicationbetweenthehepaticnicheandcancercells
AT beckwittcolinh bidirectionalexosomedrivenintercommunicationbetweenthehepaticnicheandcancercells
AT wellsalan bidirectionalexosomedrivenintercommunicationbetweenthehepaticnicheandcancercells